CARA Cara Therapeutics, Inc.

16.71
+0.00  (0%)
Previous Close 16.71
Open 16.63
Price To book 18.53
Market Cap 543.19M
Shares 32,507,000
Volume 853,811
Short Ratio 33.42
Av. Daily Volume 2,078,300

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 initiated September 2015. Placed on clinical hold February 2016. Clinical hold released April 2016 with enrollment resuming June 2016. Interim conditional power analysis due 2Q 2017.
IV CR845
Acute pain
Phase 2b trial initiated September, 2016. Data are due 2Q 2017.
CR845
Osteoarthritis (OA)
Phase 2/3 top-line data from Part A portion of trial released March 28, 2017 - endpoints met. Part B to be initiated later in 2017.
IV CR845
Uremic pruritus

Latest News

  1. Better Know a Marijuana Stock: Cara Therapeutics
  2. CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : May 26, 2017
  3. Harry Boxer: Four stocks locked in a strong uptrend
  4. ETFs with exposure to CARA Therapeutics, Inc. : May 22, 2017
  5. The Best- and Worst-Performing Marijuana Stocks Last Week
  6. Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics
  7. 3 Biotech Stocks I'd Buy Right Now
  8. CARA Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CARA-US : May 15, 2017
  9. Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017
  10. Why You're Smart to Buy Cara Therapeutics Stock
  11. CARA Therapeutics, Inc. :CARA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017
  12. Why Did Cara Therapeutics Shares Tumble 13.6% in April?
  13. Cara reports 1Q loss
  14. Cara Therapeutics Reports First Quarter 2017 Financial Results
  15. Investor Network: Cara Therapeutics Inc to Host Earnings Call
  16. Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation?
  17. Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017
  18. CARA Therapeutics, Inc. – Value Analysis (NASDAQ:CARA) : April 25, 2017
  19. ETFs with exposure to CARA Therapeutics, Inc. : April 24, 2017